Showing results (241-250 of 368) with videos related to

Sort By:
Pageof 37
European Journal of Internal Medicine|January 5, 2023
Associations of relative fat mass, a new index of adiposity, with type-2 diabetes in the general populationNavin Suthahar, Kan Wang, Victor W Zwartkruis, et al.
Lancet (London, England)|August 30, 2022
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trialsMuthiah Vaduganathan, Kieran F Docherty, Brian L Claggett, et al.
Diabetes Care|September 23, 2025
Differences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-Lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) CohortRodica Pop-Busui, Samuel P Rosin, Nicole M Butera, et al.
Diabetes Care|March 29, 2025
Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized TrialsMatthew M Y Lee, Naveed Sattar, Rodica Pop-Busui, et al.
JACC. Heart Failure|July 13, 2020
Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan: The DAPA-HF TrialScott D Solomon, Pardeep S Jhund, Brian L Claggett, et al.
European Heart Journal|August 27, 2021
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HFJames P Curtain, Kieran F Docherty, Pardeep S Jhund, et al.
European Journal of Heart Failure|May 29, 2021
Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trialScott D Solomon, Rudolf A de Boer, David DeMets, et al.
JAMA Cardiology|February 17, 2021
Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection FractionDavid D Berg, Pardeep S Jhund, Kieran F Docherty, et al.
Circulation|March 2, 2017
Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes MellitusLawrence H Young, Catherine M Viscoli, Jeptha P Curtis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2019
PET Imaging of Pancreatic Dopamine D2 and D3 Receptor Density with 11C-(+)-PHNO in Type 1 DiabetesJason Bini, Elizabeth Sanchez-Rangel, Jean-Dominique Gallezot, et al.
Pageof 37